Name of this trial: ABBV-706 M23-384 What type of cancer is this for? Relapsed/Refractory Small-cell lung cancer Who is this trial for? Patients who have progressed after prior therapy for small cell lung cancer with tarlatamab. What biomarkers are involved? N/A What is the National Clinical Trial #? NCT07365241 Brief summary of this trial: Phase 3 Randomized, Open Label, Multicenter Study to Evaluate
Archives: Clinical Trials
Lymphoma
Name of this trial: BGB-11417-303/CLL-RR1 What type of cancer is this for? Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Who is this trial for? Relapsed and/or Refractory What biomarkers are involved? CLL Cytogenics (eg, del(17p), del(11q), del(13q), and trisomy 12), complex karyotype, and the mutational status of relevant genes such as IGHV, TP53, and other CLL-related prognosis
Melanoma
Name of this trial: OptimUM-10 What type of cancer is this for? Uveal Melanoma Who is this trial for? Subjects with Primary Non-metastatic Uveal Melanoma What biomarkers are involved? Monosomy 3 What is the National Clinical Trial #? NCT07015190; https://clinicaltrials.gov/study/NCT07015190 Brief summary of this trial: A Randomized, Phase 3, Open-label Study of Neoadjuvant Darovasertib in
Multiple Myeloma
Name of this trial: Majestic-7 What type of cancer is this for? Multiple Myeloma Who is this trial for? This trial is for patients with newly diagnosed multiple myeloma who are either ineligible or not intended for stem cell transplant as initial therapy. What biomarkers are involved? n/a What is the National Clinical Trial #? NCT05552222 Brief summary of
Myelofibrosis
Pancreas
Name of this trial: AndroMETa-PDAC-288 What type of cancer is this for? Metastatic pancreatic cancer Who is this trial for? Patients who have not had any treatment for metastatic pancreatic disease. What biomarkers are involved? N/A What is the National Clinical Trial #? NCT07490301 Brief summary of this trial: Phase 2/3 Open Label Randomized Study of Telisotuzumab Adizutecan in Combination with FOLFOX
Prostate
Name of this trial: Ideate-Prostate-01 What type of cancer is this for? Prostate Cancer Who is this trial for? Patients with metastatic castration-resistant prostate cancer What biomarkers are involved? n/a What is the National Clinical Trial #? NCT06925737 Brief summary of this trial: A Phase 3, Open-label Study of Ifinatamab Deruxtecan Versus Docetaxel in Participants
Registry Trial
NAME: EXACT- Registry trial What kind of cancer is this for? All cancer types Phase: N/A Who is this trial for? Men and women who either have a diagnosis of cancer, a clinical suspicion of cancer, a diagnosis of recurrent cancer or a clinical suspicion of recurrent cancer. What biomarkers are involved? Multiple What is
Urothelial
Name of this trial: TROPION-Urothelial03 What type of cancer is this for? Urothelial Carcinoma Who is this trial for? Subjects With Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) What biomarkers are involved? TROP2 Protein Expression What is the National Clinical Trial #? NCT07129993; https://clinicaltrials.gov/study/NCT07129993 Brief summary of this trial: A Randomized, Open-Label, Phase 2/3 Study